Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mobascher

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Pharmacopsychiatry|October 23, 2008
The molecular and cellular neurobiology of nicotine abuse in schizophreniaA Mobascher, G Winterer
Pneumologie (Stuttgart, Germany)|April 24, 2008
[Mechanisms of nicotine dependence]A Mobascher, G Winterer
Der Nervenarzt|February 13, 2007
[Treatment of borderline personality disorder with atypical antipsychotic drugs]A Mobascher, J Mobascher, C Schmahl, et al.
Pharmacopsychiatry|May 25, 2006
Aripiprazole pharmacotherapy of borderline personality disorderA Mobascher, J Mobascher, V Schlemper, et al.
Neuroimage|February 9, 2010
Spontaneous brain activity and EEG microstates. A novel EEG/fMRI analysis approach to explore resting-state networksF Musso, J Brinkmeyer, A Mobascher, et al.
Deutsche Medizinische Wochenschrift (1946)|April 1, 2005
[A new method for the treatment of depression: repetitive transcranial magnetic stimulation]J Cordes, A Mobascher, M Arends, et al.
Translational Psychiatry|June 14, 2012
Hippocampal subfields predict positive symptoms in schizophrenia: first evidence from brain morphometryS Kühn, F Musso, A Mobascher, et al.
Psychological Medicine|December 11, 2012
Prenatal adversity: a risk factor in borderline personality disorder?C E Schwarze, A Mobascher, B Pallasch, et al.
Pharmacopsychiatry|December 13, 2005
Guillain-Barré syndrome after septicemia following clozapine-induced agranulocytosis. A case reportJ Mobascher, J Zielasek, F J Schuier, et al.
Neuroimage|January 27, 2009
Laser-evoked potential P2 single-trial amplitudes covary with the fMRI BOLD response in the medial pain system and interconnected subcortical structuresA Mobascher, J Brinkmeyer, T Warbrick, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Pharmacopsychiatry|October 23, 2008
The molecular and cellular neurobiology of nicotine abuse in schizophreniaA Mobascher, G Winterer
Pneumologie (Stuttgart, Germany)|April 24, 2008
[Mechanisms of nicotine dependence]A Mobascher, G Winterer
Der Nervenarzt|February 13, 2007
[Treatment of borderline personality disorder with atypical antipsychotic drugs]A Mobascher, J Mobascher, C Schmahl, et al.
Pharmacopsychiatry|May 25, 2006
Aripiprazole pharmacotherapy of borderline personality disorderA Mobascher, J Mobascher, V Schlemper, et al.
Neuroimage|February 9, 2010
Spontaneous brain activity and EEG microstates. A novel EEG/fMRI analysis approach to explore resting-state networksF Musso, J Brinkmeyer, A Mobascher, et al.
Deutsche Medizinische Wochenschrift (1946)|April 1, 2005
[A new method for the treatment of depression: repetitive transcranial magnetic stimulation]J Cordes, A Mobascher, M Arends, et al.
Translational Psychiatry|June 14, 2012
Hippocampal subfields predict positive symptoms in schizophrenia: first evidence from brain morphometryS Kühn, F Musso, A Mobascher, et al.
Psychological Medicine|December 11, 2012
Prenatal adversity: a risk factor in borderline personality disorder?C E Schwarze, A Mobascher, B Pallasch, et al.
Pharmacopsychiatry|December 13, 2005
Guillain-Barré syndrome after septicemia following clozapine-induced agranulocytosis. A case reportJ Mobascher, J Zielasek, F J Schuier, et al.
Neuroimage|January 27, 2009
Laser-evoked potential P2 single-trial amplitudes covary with the fMRI BOLD response in the medial pain system and interconnected subcortical structuresA Mobascher, J Brinkmeyer, T Warbrick, et al.
Pageof 3